Bone Health

Immunology

Hematology

Respiratory

Dermatology

Diabetes

Gastroenterology

Neurology

Oncology

Ophthalmology

Rare Disease

Rheumatology

News

All News

Product Approvals and Launches

Media

All Videos

Insights

Interviews

Peer Exchange

Podcasts

Stakeholder Summit

Compendia

Conferences

Conference Coverage

Conference Listing

CME/CE

Resources

Authors

Biosimilar Resources

Interactive Tools

Partners

Polls and Quizzes

WHEN CHOICE ARRIVES: Competition & Consequences

Subscribe

BIOSIMILAR APPROVALS

Cameron Santoro is an associate editor for The Center for Biosimilars

Videos

Here are the top 5 biosimilar articles for the week of December 30, 2024. 

The Top 5 Biosimilar Articles for the Week of December 30

Articles

To close out the year, 4 senators came together to introduce a new bipartisan bill to protect biosimilar and generic drug manufacturers from patent litigation when obtaining “skinny label” approvals for their products. 

Senators Introduce Bipartisan Legislation to Protect Skinny Labeling

First-line cetuximab beta injection has received NMPA marketing approval in RAS/BRAF wild-type metastatic colorectal cancer.

Cetuximab Biosimilar Receives NMPA Approval for RAS/BRAF Wild-Type CRC

The top 5 biosimilar-related articles of the year highlight a significant shift in the pharmaceutical industry, with projections indicating strong uptake in biosimilars at the expense of the originator products, despite challenges like uptake disparities and safety concerns.

The Top 5 Most-Read Biosimilar Articles of 2024

About

Editorial

Contact

Advisory Board

Do Not Sell My Information

Terms & Conditions

Privacy Policy

Center for Biosimilars®

Facebook

Twitter

LinkedIn

Business Practice

Business

Development

Legal

Policy

Practice

Regulatory

SAP Partners

Is your organization missing from this list? Reach out to Kaitlyn Muessen, Strategic Alliance Partnership Manager, to learn more about the complimentary strategic partnership program at kmuessen@ajmc.com.

1rem

Strategic Alliance Partnership

National Pharmaceutical Council

National Pharmaceutical Council | Strategic Alliance Partnership

Latest from National Pharmaceutical Council